<p><div class="KonaFilter image-container display-table"><div><div class="image on-image"><img src="https://static-ssl.businessinsider.com/image/5412b86d6bb3f7b27b9d1186-1200-924/ebola-14.jpg" border="0" alt="ebola"><p class="source"><span><a href="https://www.flickr.com/photos/niaid/14674486019/">Flickr/NIAID</a></span></p><p class="caption">Colorized scanning electron micrograph of filamentous Ebola virus particles (green) attached and budding from a chronically infected VERO E6 cell (orange) (25,000x magnification). </p></img></div><p></p></div></div>Shares of Chimerix dropped sharply, falling as much as 5% on Wednesday, after Thomas Eric Duncan, an Ebola patient who was being treated with the company's experimental treatment, passed away.</p>
<p><em>More to come ...</em></p>

stock market

BusinessInsider

Drug Stock Tanks After Ebola Patient Treated With Its Drug Dies

Flickr/NIAIDColorized scanning electron micrograph of filamentous Ebola virus particles (green) attached and budding from a chronically infected VERO E6 cell (orange) (25,000x magnification). Shares of Chimerix dropped sharply, falling as much as 5% on Wednesday, after Thomas Eric Duncan, an Ebola patient who was being treated with the company's experimental treatment, passed away. More to come ...

FlickrNIAIDColorized scanning electron micrograph of filamentous Ebola virus particles green attached and budding from a chronically infected VERO E6 cell orange 25,000x magnification.  Shares of Chimerix dropped sharply, falling as much as 5 on Wednesday, after Thomas Eric Duncan, an Ebola patient who was being treated with the companys experimental treatment, passed away.

Drug Stock Tanks After Ebola Patient Treated With Its Drug Dies

Myles Udland

READ MORE ARTICLES ON

Popular Right Now